Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

New Study Suggests VDC May Cause Malignant Mesothelioma

By Schiff Hardin Product Liability and Mass Torts on July 1, 2014
Email this postTweet this postLike this postShare this post on LinkedIn
480857177

Does exposure to vinylidene chloride (VDC) cause malignant mesothelioma?  According to a new study, the answer may be yes.  A two-year National Toxicology Program study found that a particular species of male rat exposed to VDC resulted in a marked increase in malignant mesothelioma.  According to the study, “a chronic, pro-inflammatory environment associated with VDC exposure may exacerbate disturbances in oncogene, growth factor, and cell cycle regulation, resulting in an increased incidence of mesothelioma.”  The study concludes that VDC exposure may lead to cytotoxicity and DNA damage resulting in hyperplasia and genetic instability that are important risk factors in the development of cancer.

Vinylidene chloride is used to make various chemical intermediaries and is used in the manufacture of several different materials including films, coatings, plastic pipes, conduit, flooring, sheeting, and cables.  The National Institute of Occupational Safety and Health (NIOSH) considers VDC an irritant to the eyes, skin, and throat as well as a potential carcinogen.

The National Toxicology Program is located at the National Institute of Environmental Health Sciences and is part of the National Institutes of Health.  The study can be found at http://www.ncbi.nlm.nih.gov/pubmed/24958746

  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Product Liability & Mass Torts Blog
  • Organization:
    ArentFox Schiff LLP

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo